Our COVID-19 vaccine appears to work against UK, South African variants: Moderna

America's Moderna on Monday said that its COVID-19 vaccine triggered an immune response that protected against two variants of the virus first detected in Britain and South Africa in laboratory tests. However, those antibodies were less efficient at neutralising the South African variant. Moderna said it would test a vaccine booster against the South Africa variant in pre-clinical trials.